Qualigen Therapeutics (QLGN) announced that it will implement a 1-for-50 reverse stock split of the issued shares of its common stock, effective at 12:01 a.m. Eastern time on November 5, 2024. The Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on Tuesday, November 5, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol “QLGN.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QLGN:
- Qualigen Therapeutics files to sell 14M shares of common stock
- Qualigen Therapeutics Board Experiences Key Changes
- Qualigen Therapeutics Announces Executive Shakeup and Board Revamp
- Qualigen Therapeutics appoints Kevin Richardson as Interim CEO and CFO
- Qualigen Therapeutics Granted Nasdaq Listing Extension